Immune Response News and Research

RSS

Ebola vaccine that provides a year’s worth of protection developed

Liberia’s Ebola outbreak has yielded a successful trial of two vaccines against the deadly infection that could provide protection for up to a year and is also deemed to be safe.

12 Oct 2017

Calcium controls use of glucose by T cells to multiply and battle against infection, study finds

A calcium signal controls whether immune cells can use the nutrients needed to fuel their multiplication into a cellular army designed to fight invading viruses.

11 Oct 2017

Maternal immune activation linked to ASD symptom severity in children with autism

The retrospective cohort study of 220 Australian children, conducted between 2011-2014, indicates that a "an immune-mediated subtype" of autism driven by the body's inflammatory and immunological systems may be pivotal, according to the University of Sydney's Professor Adam Guastella.

10 Oct 2017

Penn study explains how acute viral infections can linger

Infections caused by viruses, such as respiratory syncytial virus, or RSV, measles, parainfluenza, and Ebola, are typically considered acute. These viruses cause disease quickly and live within a host for a limited time. But in some cases, the effects of the infection, and presence of the virus itself, can persist.

6 Oct 2017

Ebola vaccine found to be safe and effective for adults and children in Africa

Experts at St George's, University of London, have reported that an Ebola vaccine is safe for children as well as adults and produces an immune response.

6 Oct 2017

Monoclonal antibody “cocktail” inhibits Zika infection, study reveals

A collaborative study conducted by the Miller School of Medicine, University of Miami has revealed that a monoclonal antibody “cocktail” inhibited zika virus (ZIKV) infection in primates.

5 Oct 2017

New DNA-based Zika vaccine demonstrates safety and ability to elicit immune response

A new generation DNA-based Zika vaccine is the first to demonstrate both safety and the ability to elicit an immune response against Zika in humans, according to new research from the Perelman School of Medicine at the University of Pennsylvania, conducted in partnership with The Wistar Institute, Inovio Pharmaceuticals, and GeneOne Life Science, Inc.

5 Oct 2017

Zinc may help stop growth of esophageal cancer

Researchers at the University of Texas at Arlington have discovered that zinc targets and blocks a specific calcium channel in esophageal cancer cells, preventing them from proliferating.

2 Oct 2017

Rogue messengers can negatively affect the body's immune system response against cancer

Researchers from Trinity College Dublin have made a discovery around treatment-resistant breast cancer that may turn the phrase, 'don't shoot the messenger', on its head. The scientists have found that cell to cell messengers released by cancer cells which are not responding to treatment, can negatively affect the body's immune system response against cancer.

28 Sep 2017

Cancer vaccines need to target immune fighters that can withstand battle against malicious tumors

Cancer vaccines may need to better target T cells that can hold up to the long fight against cancer, scientists report.

27 Sep 2017

High-speed method generates mini-protein binders with potential to become new class of drugs

Scientists have created a high-speed method to generate thousands of different, small, stable proteins from scratch that can be custom-designed to bind to specific therapeutic targets.

27 Sep 2017

Cellular messaging mechanism could lead to new way of treating disease

A newly discovered cellular messaging mechanism could lead to a new way to deliver therapeutics to tissues affected by disease, according to a new study from Harvard T.H. Chan School of Public Health.

27 Sep 2017

Scientists gain insight into how Ebola virus uses the body's defenses to speed up infection

Scientists from The University of Texas Medical Branch at Galveston have gained new insight into how the Ebola virus uses the body's natural defenses to speed the rate of infection and unleash its lethal disease, according to a new report in mBio.

26 Sep 2017

Potential Zika vaccine blocks mother-to-fetus transmission and stops male testis infection

For the first time, a collaborative team led by The University of Texas Medical Branch at Galveston has shown that a potential Zika vaccine quickly can protect fetuses against infection as well as protect males against testicular infection and injury.

26 Sep 2017

Drug targeting approach could lead to improved therapies for immune-related diseases

A new technique that targets drugs to specific cells could lead to improved therapies for diseases caused by an overactive immune response.

25 Sep 2017

Novel assay shows potential to detect circulating cancer biomarkers in blood samples

Future Science Group today announced the publication of an article in Future Science OA presenting early data from a novel assay for the non-invasive detection of PD-L1 and other biomarkers in patient blood samples.

22 Sep 2017

Novel gene therapy can inhibit, reverse multiple sclerosis in mouse models

Multiple sclerosis can be inhibited or reversed using a novel gene therapy technique that stops the disease's immune response in mouse models, University of Florida Health researchers have found.

21 Sep 2017

New study shows how staph cells evade the body's immune system

For years, medical investigators have tried and failed to develop vaccines for a type of staph bacteria associated with the deadly superbug MRSA. But a new study by Cedars-Sinai investigators shows how staph cells evade the body's immune system, offering a clearer picture of how a successful vaccine would work.

21 Sep 2017

High-dose flu vaccine could protect middle-aged adults with chronic conditions

Expanding the high-dose influenza vaccine recommendation to include middle-aged adults with chronic health conditions may make economic sense and save lives, report scientists at the University of Pittsburgh School of Medicine.

21 Sep 2017

Poliovirus therapy triggers longer-lasting immune response against malignant tumors

An investigational therapy using modified poliovirus to attack cancer tumors appears to unleash the body's own capacity to fight malignancies by activating an inflammation process that counter's the ability of cancer cells to evade the immune system.

20 Sep 2017

Immune Response News and Research

Ebola vaccine that provides a year’s worth of protection developed

Calcium controls use of glucose by T cells to multiply and battle against infection, study finds

Maternal immune activation linked to ASD symptom severity in children with autism

Penn study explains how acute viral infections can linger

Ebola vaccine found to be safe and effective for adults and children in Africa

Monoclonal antibody “cocktail” inhibits Zika infection, study reveals

New DNA-based Zika vaccine demonstrates safety and ability to elicit immune response

Zinc may help stop growth of esophageal cancer

Rogue messengers can negatively affect the body's immune system response against cancer

Cancer vaccines need to target immune fighters that can withstand battle against malicious tumors

High-speed method generates mini-protein binders with potential to become new class of drugs

Cellular messaging mechanism could lead to new way of treating disease

Scientists gain insight into how Ebola virus uses the body's defenses to speed up infection

Potential Zika vaccine blocks mother-to-fetus transmission and stops male testis infection

Drug targeting approach could lead to improved therapies for immune-related diseases

Novel assay shows potential to detect circulating cancer biomarkers in blood samples

Novel gene therapy can inhibit, reverse multiple sclerosis in mouse models

New study shows how staph cells evade the body's immune system

High-dose flu vaccine could protect middle-aged adults with chronic conditions

Poliovirus therapy triggers longer-lasting immune response against malignant tumors

Exploring Strategies for Targeting Kinases in Innate Immunity eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News